InspireMD Grants 18,000 Restricted Shares to a New Employee
InspireMD has granted 18,000 restricted shares to one new non-executive employee as an employment incentive, according to GlobeNewswire. The shares vest over three years.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
InspireMD, Inc., maker of the CGuard Prime carotid stent system, reported through GlobeNewswire that its Compensation Committee approved an inducement award for one newly hired non-executive employee. The package totals 18,000 shares of restricted stock, with a grant date of November 19, 2026.
The award sits outside the company's 2021 Equity Incentive Plan and is issued under its 2024 Inducement Plan, which is limited to people who were not previously employees or who return after a genuine break. The grant follows Nasdaq Listing Rule 5635(c)(4), the exception that allows such awards without shareholder approval.
The shares vest over three years: one third on the first anniversary, and the remainder in two equal parts on the second and third anniversaries, provided the employee stays with the company. The company trades on Nasdaq under the ticker NSPR.
why it matters
For investors this is a routine filing with a small share count, so it is unlikely to move the stock on its own. Staggered vesting ties the employee's pay to the company's share price and supports retention.
tags
instruments
sources
- InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — globenewswire.com, 20 November 2026 at 21:05 UTC
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — TradingView, 20 November 2026 at 21:05 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗